Daniel Gray: Immunotherapy for BRCA1 Cancers (AUDIO)
Caption
Researchers have found a new way to use immunotherapy, a breakthrough mode of cancer treatment which harnesses the patient's immune system, to treat an aggressive form of breast cancer.
The researchers from Melbourne's Walter and Eliza Hall Institute and Peter MacCallum Cancer Centre have shown, for the first time, that combining two immunotherapy drugs could be effective in treating triple negative breast cancers arising in women with BRCA1 mutations.
Dr. Daniel Gray explains why the research team looked at immunotherapies for BRCA1-related breast cancers.
Credit
Walter and Eliza Hall Institute
Usage Restrictions
None
License
Licensed content